First Quadrant’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-55,400
| Closed | -$869K | – | 515 |
|
|
2021
Q4 | $869K | Hold |
55,400
| – | – | 0.09% | 181 |
|
|
2021
Q3 | $950K | Hold |
55,400
| – | – | 0.11% | 161 |
|
|
2021
Q2 | $1.19M | Hold |
55,400
| – | – | 0.14% | 143 |
|
|
2021
Q1 | $832K | Buy |
+55,400
| New | +$832K | 0.09% | 186 |
|
|
2020
Q3 | – | Sell |
-4,365
| Closed | -$50K | – | 720 |
|
|
2020
Q2 | $50K | Sell |
4,365
-42,095
| -91% | -$482K | 0.01% | 632 |
|
|
2020
Q1 | $481K | Buy |
+46,460
| New | +$481K | 0.07% | 271 |
|
|
2019
Q2 | – | Sell |
-32,011
| Closed | -$589K | – | 756 |
|
|
2019
Q1 | $589K | Buy |
32,011
+2,211
| +7% | +$40.7K | 0.05% | 336 |
|
|
2018
Q4 | $779K | Sell |
29,800
-7,229
| -20% | -$189K | 0.06% | 272 |
|
|
2018
Q3 | $850K | Sell |
37,029
-7,111
| -16% | -$163K | 0.02% | 407 |
|
|
2018
Q2 | $841K | Hold |
44,140
| – | – | 0.02% | 424 |
|
|
2018
Q1 | $744K | Buy |
+44,140
| New | +$744K | 0.01% | 433 |
|
|
2015
Q4 | – | Sell |
-400
| Closed | -$5K | – | 843 |
|
|
2015
Q3 | $5K | Buy |
+400
| New | +$5K | ﹤0.01% | 783 |
|